More Information on 'NanoTemper Technologies GmbH'

NanoTemper Technologies is a company that provides biophysical tools and solutions for drug discovery and development. The company's core products include Prometheus, Dianthus, Monolith, and Andromeda, which are designed to help scientists characterize complex therapeutics, screen for potential drug candidates, and measure binding affinities. These tools use various biophysical methods, such as spectral shift and temperature-related intensity change, to provide high-quality data on protein stability, binding interactions, and other biophysical properties. The company's products are designed to be easy to learn and use, and are supported by strong scientific expertise and customer support. Overall, NanoTemper Technologies aims to provide innovative solutions to help scientists overcome challenges in drug discovery and development, and to accelerate the development of new therapies.

About NanoTemper Technologies GmbH
NanoTemper’s mission is to enable researchers to do the best science of their lives, we’re a passionate team! Stefan Duhr and Philipp Baaske set out to build a company to address challenges researchers were facing with the ultimate goal of helping to move science forward. NanoTemper was started in 2008 after Stefan and Philipp met at Ludwig-Maximilians-University Munich. At the time, the effect of thermophoresis was not known within the Life Sciences community, but Stefan and Philipp knew that it was important. Realizing the shortcomings of current protein research techniques, they came up with a method, MicroScale Thermophoresis that was enormously sensitive, and would bring researchers one step closer to developing better drugs faster. Now, NanoTemper has over 120 employees in 10 offices around the world including Munich, Germany; Cambridge, UK; Kraków, Poland; Copenhagen, Denmark; South San Francisco and Boston, USA; Sao Paulo, Brazil; St. Petersburg, Russia; Bangalore, India and Beijing, China.

Looking for Channel Partners in: